A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

International journal of chronic obstructive pulmonary disease

Volumn 4, Issue , 2009, Pages 253-263

  Hilleman, Daniel E ^a   Malesker, Mark A ^a   Morrow, Lee E ^a   Schuller, Dan ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGED; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; DOSE RESPONSE; DRUG ADMINISTRATION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; TIME;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; CARDIOVASCULAR DISEASES; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS;

MLCS; MLOWN;

EID: 75649113034     PISSN: None     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/copd.s4620     Document Type: Review

References (25)